Biotech

All Articles

Ideaya bags option on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M loss on neglected epilepsy drug, touts FDA manage

.Our team currently understand that Takeda is actually hoping to discover a course to the FDA for ep...

VBI Vaccinations files for bankruptcy, seeks asset sale

.Immunology biotech VBI Vaccinations is actually turning hazardously near to the climax, with progra...

Celldex anti-cKIT antitoxin minimize hives in one more stage 2 study

.It's not easy to muscle in on a room as affordable as immunology, however Celldex Rehabs believes t...

Boehringer offers up to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics as well as a preclinical...

Ventyx's last hope for inflamed med ends in Crohn's failure

.Ventyx Biosciences' Crohn's condition medicine did certainly not aid people obtain remission in a p...

Cognition's stage 2 beam records taint Alzheimer's prospect

.Cognition Therapeutics' stage 2 sparkle test has taken several of the gloss off the Alzheimer's con...

BMS centers bispecific months after filing to function period 3 trial

.Bristol Myers Squibb has possessed a whiplash change of heart on its BCMA bispecific T-cell engager...

Charles Baum consumes Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who managed Mirati Therapies' $ 5.8 billion purchase to Bristol Myers Sq...

Asarina to shut after attempts to companion Tourette's medicine fall short

.After connecting to more than 200 providers to companion a Tourette disorder therapy that showed th...